Anti SARS-CoV-2 Monoclonal Antibodies in Pre-Exposure or Post-Exposure in No- or Weak Responder to Vaccine Kidney Transplant Recipients: Is One Strategy Better than Another?

<b>Background:</b> Kidney transplant recipients (KTRs) are likely to develop severe COVID-19 and are less well-protected by vaccines than immunocompetent subjects. Thus, the use of neutralizing anti–SARS-CoV-2 monoclonal antibodies (mAbs) to confer a passive immunity appears attractive in KTRs. <b>M...

Descrición completa

Detalles Bibliográficos

Principais autores:	Anais Romero, Charlotte Laurent, Ludivine Lebourg, Veronique Lemée, Mélanie Hanoy, Frank Le Roy, Steven Grange, Mathilde Lemoine, Dominique Guerrot, Dominique Bertrand
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2024-02-01
Series:	Viruses
Assuntos:	COVID-19 monoclonal antibodies SARS-CoV-2 kidney transplantation
Acceso en liña:	https://www.mdpi.com/1999-4915/16/3/381
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!